NORDEA INVESTMENT MANAGEMENT AB
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1218210
STOCKHOLM, V7
Position in LGND
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$15,786,482
+$5,617,111 QoQ
Shares Held
49,943
-1.9% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 413 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. LGND ranks #4 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
This page
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,786,482 | 49,943 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $10,169,371 | 50,936 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,157,785 | 53,725 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $10,805,716 | 61,001 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $6,668,468 | 58,660 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $6,164,568 | 58,632 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,275,988 | 58,572 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $5,565,203 | 55,602 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $4,945,977 | 58,699 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,994,776 | 68,328 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $4,925,908 | 68,971 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $4,275,411 | 71,352 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,201,870 | 72,148 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $5,270,059 | 71,643 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $4,934,716 | 73,873 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,022,530 | 69,940 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $6,261,008 | 70,175 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $8,137,867 | 72,343 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $11,034,001 | 71,436 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $10,026,437 | 71,967 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $9,585,266 | 73,064 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $9,895,221 | 64,908 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,581,498 | 66,179 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,959,211 | 41,536 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $9,230,976 | 82,530 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,987,407 | 41,081 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||